Schedule 13G ownership disclosure

C4 Therapeutics Inc

Security class unavailable · CUSIP: 12529R107

Event date: 2023-07-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001273087-23-000125
Form type
SC 13G
Filer
C4 Therapeutics, Inc.
CIK
CIK 1662579
Filed
Jul 25, 2023
Reporting period
Jul 19, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub